(Reuters) – Advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend use of COVID-19 booster shots redesigned to target the BA.4 and BA.5 Omicron subvariants of the coronavirus for people aged 12 years and older.
The panel members voted 13-to-1 in favor of both the updated boosters by Pfizer/BioNTech and Moderna.
The so-called bivalent shots also include the original version of the virus targeted by all previous COVID-19 vaccines.
(Reporting by Leroy Leo in Bengaluru; Editing by Bill Berkrot)
